Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Clinical Chemistry and Laboratory Medicine|December 3, 2015
Comparative analysis of prostate cancer specific biomarkers PCA3 and ERG in whole urine, urinary sediments and exosomesRianne J Hendriks, Siebren Dijkstra, Sander A Jannink, et al.
BJU International|March 14, 2008
The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging systemInge M van Oort, J Alfred Witjes, Dieuwertje E G Kok, et al.
World Journal of Urology|October 1, 2015
PREDICT: model for prediction of survival in localized prostate cancerLinda G W Kerkmeijer, Evelyn M Monninkhof, Inge M van Oort, et al.
The Prostate|January 7, 2015
Known susceptibility SNPs for sporadic prostate cancer show a similar association with "hereditary" prostate cancerRuben G Cremers, Tessel E Galesloot, Katja K Aben, et al.
Cancers|June 22, 2023
Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate CancerPeter H J Slootbeek, Iris S H Kloots, Inge M van Oort, et al.
The Prostate|March 19, 2016
The clinical phenotype of hereditary versus sporadic prostate cancer: HPC definition revisitedRuben G Cremers, Katja K Aben, Inge M van Oort, et al.
BJU International|September 25, 2025
The benefits of PCNL combined with ureterorenoscopy compared to isolated PCNL in urolithiasis (PRECISE): a multicentre randomised controlled trial protocolChris A Suijker, Riemer A Kingma, Dirk Bakker, et al.
British Journal of Clinical Pharmacology|September 8, 2017
Drug-drug interaction potential in men treated with enzalutamide: Mind the gapGuillemette Emma Benoist, Inge M van Oort, Stella Smeenk, et al.
British Journal of Clinical Pharmacology|August 26, 2021
The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancerEmmy Boerrigter, Guillemette E Benoist, Joanneke K Overbeek, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 9, 2021
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223Maarten J van der Doelen, Agnes Stockhaus, Yuanjun Ma, et al.
Pageof 14